Enliven Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6M | 80k | 20.47 |
| 2025-06-30 | $2.8M | 138k | 20.06 |
| 2025-03-31 | $1.4M | 70k | 19.68 |
| 2024-12-31 | $2.0M | 87k | 22.50 |
| 2024-09-30 | $707k | 28k | 25.54 |
| 2024-06-30 | $470k | 20k | 23.37 |
| 2024-03-31 | $472k | 27k | 17.59 |
| 2023-09-30 | $1.4k | 105 | 13.67 |
| 2023-06-30 | $1.7k | 81 | 20.41 |
| 2023-03-31 | $7.3k | 334 | 21.90 |